Loading live market data…

BridgeBio Pharma, Inc.

NASDAQ:BBIO

$82.66 USD

-$1.43 (-1.7%)

Volume
1.94M
Average Volume
3.63M
Market Capitalization
$16.19B
P/E Ratio
-22.04
Dividend Yield
0.00%
Price Target
$100.00
Year High
$93.42
Year Low
$42.09
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.44

BBIO Estimated and Actual Revenue by Quarter

BBIO Estimated and Actual EPS by Quarter

BBIO Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2029-12-31 11 -1.19B -979.25M -1.05B -1.19B -979.25M -1.05B
2029-09-30 10 -1.1B -907.16M -971.42M -1.1B -907.16M -971.42M
2029-06-30 10 -1.02B -839.91M -899.41M -1.02B -839.91M -899.41M
2029-03-31 11 -936.02M -772.83M -827.57M -936.02M -772.83M -827.57M
2028-12-31 6 -770M -635.76M -680.79M -770M -635.76M -680.79M
2028-09-30 5 -700.35M -578.25M -619.2M -700.35M -578.25M -619.2M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2029-12-31 11 421.94M 540.28M 461.63M 4.54B 5.5B 4.86B
2029-09-30 10 390.14M 499.56M 426.84M 4.21B 5.1B 4.51B
2029-06-30 10 361.76M 463.22M 395.79M 3.9B 4.72B 4.17B
2029-03-31 11 333.33M 426.81M 364.69M 3.59B 4.34B 3.84B
2028-12-31 6 204.83M 262.27M 224.1M 2.95B 3.57B 3.16B
2028-09-30 5 161.78M 207.16M 177.01M 2.68B 3.25B 2.87B
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2029-12-31 11 979.25M 1.19B 1.05B 2 2.16611 2.77363 2.3699
2029-09-30 10 907.16M 1.1B 971.42M 2 2.00287 2.56461 2.1913
2029-06-30 10 839.91M 1.02B 899.41M 2 1.85717 2.37805 2.0319
2029-03-31 11 772.83M 936.02M 827.57M 4 1.71121 2.19115 1.8722
2028-12-31 6 635.76M 770M 680.79M 5 1.05152 1.34644 1.15045
2028-09-30 5 578.25M 700.35M 619.2M 5 0.83056 1.06351 0.9087